IL161588A0 - Method and composition for dry eye treatment - Google Patents

Method and composition for dry eye treatment

Info

Publication number
IL161588A0
IL161588A0 IL16158801A IL16158801A IL161588A0 IL 161588 A0 IL161588 A0 IL 161588A0 IL 16158801 A IL16158801 A IL 16158801A IL 16158801 A IL16158801 A IL 16158801A IL 161588 A0 IL161588 A0 IL 161588A0
Authority
IL
Israel
Prior art keywords
film
eye
composition
mixture
dry eye
Prior art date
Application number
IL16158801A
Other languages
English (en)
Original Assignee
Yissum Res Dev Co
Novagali Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co, Novagali Pharma Sa filed Critical Yissum Res Dev Co
Publication of IL161588A0 publication Critical patent/IL161588A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
IL16158801A 2001-11-01 2001-11-01 Method and composition for dry eye treatment IL161588A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IL2001/001015 WO2003053405A1 (en) 2001-11-01 2001-11-01 Method and composition for dry eye treatment

Publications (1)

Publication Number Publication Date
IL161588A0 true IL161588A0 (en) 2004-09-27

Family

ID=11043109

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16158801A IL161588A0 (en) 2001-11-01 2001-11-01 Method and composition for dry eye treatment

Country Status (11)

Country Link
EP (1) EP1441696B1 (xx)
JP (1) JP2005513097A (xx)
CN (1) CN100335036C (xx)
AT (1) ATE468107T1 (xx)
AU (1) AU2002214233A1 (xx)
CA (1) CA2464243C (xx)
DE (1) DE60142187D1 (xx)
ES (1) ES2343512T3 (xx)
HK (1) HK1067316A1 (xx)
IL (1) IL161588A0 (xx)
WO (1) WO2003053405A1 (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
WO2006003519A2 (en) * 2004-07-02 2006-01-12 Novagali Pharma Sa Use of emulsions for intra: and periocular injection
ATE439123T1 (de) * 2004-07-02 2009-08-15 Novagali Pharma Sa Verwendung von emulsionen zur intra- und periocularen injection
JP5272307B2 (ja) * 2004-07-16 2013-08-28 大正製薬株式会社 水性点眼剤
DE602004017477D1 (de) 2004-11-09 2008-12-11 Novagali Pharma Sa Öl-in-Wasser-Emulsion mit niedriger Konzentration des kationischen Mittels und positivem Zetapotential
EP1929996B1 (en) 2004-11-09 2011-02-16 Novagali Pharma S.A. Ophthalmic emulsions containing an immunosuppressive agent
CN101175475B (zh) * 2005-05-10 2010-04-14 爱尔康公司 包含活性成分、泊洛沙姆或美洛沙泊表面活性剂和二醇的混悬制剂、其用于生产治疗眼科病症的药物的用途
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US8288348B2 (en) 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
DK1937212T3 (da) 2005-10-10 2010-12-13 Novagali Pharma Sa Oftalmiske emulsioner indeholdende prostaglandiner
US11311477B2 (en) 2006-03-07 2022-04-26 Sgn Nanopharma Inc. Ophthalmic preparations
US10137083B2 (en) * 2006-03-07 2018-11-27 SGN Nanopharma Inc Ophthalmic preparations
EP1834635B1 (en) * 2006-03-13 2011-07-06 Advanced in Vitro Cell Technologies, S.L. Stable nanocapsule systems for the administration of active molecules
US20070280902A1 (en) 2006-06-01 2007-12-06 Laura Rabinovich-Guilatt Method for treating eye disease or conditions affecting the posterior segment of the eye
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
CN101130058B (zh) * 2006-08-23 2011-10-05 华北制药集团新药研究开发有限责任公司 一种环孢菌素a眼用乳剂及其制备方法
WO2008120249A1 (en) 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
EP2308468A1 (en) 2009-10-08 2011-04-13 Novaliq GmbH Novel pharmaceutical composition comprising a macrolide immunosuppressant drug
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
US10172789B2 (en) 2013-01-24 2019-01-08 Palvella Therapeutics Llc Compositions for transdermal delivery of mTOR inhibitors
EP3565520A4 (en) 2017-01-06 2020-08-19 Palvella Therapeutics, Inc. Anhydrous compositions of MTOR inhibitors and method of use
US11000513B2 (en) 2018-07-02 2021-05-11 Palvella Therapeutics, Inc. Anhydrous compositions of mTOR inhibitors and methods of use
CN109010270B (zh) * 2018-09-03 2021-07-30 辅必成（上海）医药科技有限公司 一种阳离子材料制备的眼用乳

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101241A (en) * 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
DE10036871A1 (de) * 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe

Also Published As

Publication number Publication date
ES2343512T3 (es) 2010-08-03
CN1558751A (zh) 2004-12-29
AU2002214233A1 (en) 2003-07-09
ATE468107T1 (de) 2010-06-15
EP1441696A1 (en) 2004-08-04
DE60142187D1 (de) 2010-07-01
CN100335036C (zh) 2007-09-05
EP1441696B1 (en) 2010-05-19
CA2464243A1 (en) 2003-07-03
CA2464243C (en) 2010-01-19
HK1067316A1 (en) 2005-04-08
JP2005513097A (ja) 2005-05-12
WO2003053405A1 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
HK1067316A1 (en) Method and composition for dry eye treatment
AU655919B2 (en) Artificial tears
JP2005513097A5 (xx)
DE69115990D1 (de) Zusammensetzung zur Behandlung von Dry Eye Erkrankungen
BR9915536A (pt) Composição e método para cuidados com o tecido
BR9610849A (pt) Composição de limpeza pessoal e processo para a inibiçao da perda de umidade pela pele e proteção da pele
DE3874479D1 (de) Loesung zur behandlung von "dry-eye"-erkrankungen.
BR0011883A (pt) Composição, produto para cabelos, produto para pele, e, processo de tratamento dos cabelos ou da pele
KR870002830A (ko) 고농도-오일-함유 무수 발포성 조성물
ATE200974T1 (de) Haarwaschmittel mit konditionierenden eigenschaften die bestimmte haarkonditionierende ester enthalten
TR199800437T1 (xx) Mikro em�lsiyonlar.
RU94045136A (ru) Композиция для ухода за кожей, способ ухода за кожей
HK1110198A1 (en) Microemulsion & sub-micron emulsion process & compositions
JP2006521282A (ja) ポリエニルホスファチジルコリン及びアルカノールアミンを使用する皮膚創傷の治療
BR9711832A (pt) Composições lìquidas para a limpeza pessoal que contêm óleos e tensoativos sintéticos
WO2019030458A3 (fr) Emulsion moussante a haute teneur en huile et ses utilisations, notamment pour l'hygiene corporelle
AU2002224826A1 (en) Vesicle forming skin oil containing w/o-emulsifiers with a hydrophilic-lipophilic balance of 2-6, method for the production and use thereof
BRPI0406879A (pt) Dispositivo de liberação sustentada e método para a liberação ocular de agentes adrenérgicos
MA21492A1 (fr) Compositions en emulsions contenant des agents emulsionnants amphipathiques .
US4261061A (en) Process of treating athletic socks to prevent shoe irritation or blisters of the feet, and product
MXPA05003851A (es) Composicion cosmetica de tipo emulsion de agua en aceite que contiene una sal activa desodorante y un emulsor derivado de poliolefina que lleva al menos una parte polar.
US6718914B2 (en) Method for neutralizing offensive chemical odors
US20090011050A1 (en) Skin Treatment Composition And Method
MX2022014226A (es) Composiciones para la administracion de agentes bioactivos en foliculos pilosos.
JP2004143064A (ja) 美白用組成物

Legal Events

Date Code Title Description
FF Patent granted